Glaxo Smith Kline
Glaxo smith kline
AstraZeneca
Astrazeneca
Amgen
AMGEN
Bristol Myers Squibb
BMS
Daiichi-Sankyo
DSI
Exact sciences
Lilly
Eli Lilly
Johnson & Johnson
Johnson & Johnson
Merck
MERCK
Roche
ROCHE
Synnovation Therapeutics
Synnovation
© Drug Development Program – Phase 1 | Princess Margaret Cancer Centre, UHN. All Rights Reserved.